Abstract
In view of the increasing interest in measurement of aluminum in plasma of hemodialysis patients and the analytical difficulties, which may lead to false clinical interpretations, we organized an international interlaboratory quality-control program that has operated since 1983. The results obtained after four years (72 participants) demonstrate a lessened discrepancy of the results. This program allowed some laboratories to improve their results and even to solve some of their analytical problems. This surveillance will be continued and extended to include the analysis of dialysis fluids.
Industrial application of fluidized-bed combustion: Phase I. Quarterly technical progress report, April 1--June 30, 1978